Summary
- Closed for EoI
- Profile Type
- Research & Development Request
- POD Reference
- RDRIT20241218023
- Term of Validity
- 18 December 2024 - 18 December 2025
- Company's Country
- Italy
- Type of partnership
- Research and development cooperation agreement
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- Italian startup is looking for partners to respond to IHI Call 9, Topic 4 by addressing critical challenges in data privacy, security, and interoperability. The startup offers a decentralized consent management solution that gives patients full control over their data, i.e. data stored in centralised repositories (Electronic Health Records) and real-time data streams from connected devices (wereables). This solution fully aligns with the European Health Data Spaces architecture.
- Full Description
-
The Italian startup is uniquely positioned to add value to a consortium seeking to respond to IHI Call 9, Topic 4 by addressing critical challenges in data privacy, security, and interoperability. Their core Privacy Enhancing Technologies—Data Visibility Control Overlay (DVCO) and Record-Level Encryption Scheme (RELE) - together with their Data Ownership Platform (DOP) middleware are fully aligned with the European Health Data Spaces architecture. These technologies enable decentralized, privacy-enhancing solutions that empower patients to control their data while supporting cutting-edge digital health innovations and ensuring interoperable data exchange across borders.
Addressing Key Challenges in Healthcare Data Sharing
One of the biggest challenges in healthcare today is the centralization of patient consent management. Centralized systems are costly to implement and maintain, requiring significant resources for infrastructure, administration, and compliance. They also limit patient autonomy and create bottlenecks that slow down data-sharing efforts, especially when managing consent across multiple platforms and stakeholders.
As healthcare organizations scale their data-sharing initiatives, centralized models become increasingly inefficient. Some organizations attempt to bypass these challenges by anonymizing data, but this approach presents significant limitations—particularly with real-time data streams generated by connected devices such as wearables. Anonymizing such data is not only technically difficult, but the risk of re-identification remains high, especially when cross-referenced with other datasets. Furthermore, anonymized data is often insufficient for clinical care, where identifiable information is crucial for providing personalized treatments and making real-time decisions.
Recognizing these challenges, The startup offers a decentralized consent management solution that empowers patients with full control over their data, including both data stored in centralised repositories (Electronic Health Records) and real-time data streams from connected devices. This approach eliminates the cost and complexity of centralized systems, ensures compliance with GDPR, and aligns with the objectives of the European Health Data Space. By giving patients the ability to manage their data on their own terms, The startup enhances trust in data-sharing practices, fostering innovation and collaboration in the healthcare ecosystem.
Ideal consortium Partners
The ideal consortium will bring together expertise from the following sectors:
1. Clinics & Hospitals
o Contributing healthcare knowledge to design an optimal user experience for both patients and healthcare operators.
o Providing expertise to develop relevant AI algorithms based on real-world clinical practices and requirements.
2. Pharmaceutical Companies & Medical Research Centers
o Offering insights into the types of data and data analytics needed for research and clinical trials.
o Ensuring the effective use of healthcare data to drive innovation in drug discovery and treatment protocols.
3. Medical Device Providers
o Supplying medical devices equipped with The startup's DVCO technology to enable seamless data capture and sharing.
4. AI Companies
o Leveraging healthcare data to develop innovative AI algorithms for:
Disease prediction and prevention.
Emergency assistance and intervention.
5. Front-End Web Application Development Companies
o Designing and developing user-centric front-end interfaces to ensure an optimal and intuitive user experience for all stakeholders.
6. IT Service Providers
o Integrating the Health Data Exchange Hub within existing clinical system architectures.
o Providing the infrastructure and technical support required to deploy and operate the Health Data Exchange Hub efficiently. - Advantages and Innovations
-
Core Technologies to Support the IHI Call’s Objectives
Data Visibility Control Overlay (DVCO)
Functionality: Enables granular control over data visibility, allowing patients to decide who can access their data, for what purpose, and for how long. Ensures compliance with GDPR and the Data Act, supporting real-time and secure sharing of health data.
Benefits:
For hospitals and device manufacturers: Facilitates patient-driven data sharing from devices (e.g., wearables), enabling compliance by design.
For pharmaceutical companies and researchers: Provides secure access to real-time health data, accelerating research and clinical trials while ensuring alignment with the European Health Data Spaces framework.
Record-Level Encryption Scheme (RELE)
Functionality: Allows selective encryption of health records, enabling patients to share specific data for research or treatment while keeping other information private. Ensures privacy in centralized systems like EHRs and supports interoperability under European Health Data Spaces.
Benefits:
For hospitals: Ensures only authorized healthcare providers access specific patient records, improving trust and GDPR compliance.
For pharmaceutical companies and researchers: Facilitates privacy-compliant research with selective data access while ensuring secure, cross-border data exchange.
Data Ownership Platform (DOP)
Functionality: Open-source middleware for decentralized consent management, integrating DVCO and RELE into existing systems. Supports Health Data Exchange Hubs for secure real-time and stored health data sharing. Fully compliant with GDPR and aligned with European Health Data Spaces.
Benefits:
For healthcare providers, researchers, and manufacturers: Simplifies secure and interoperable data exchange while maintaining patient control. Promotes large-scale collaboration within European Health Data Spaces for compliant secondary use of health data. - Stage of Development
- Already on the market
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
- IPR description
-
The ideal consortium will bring together expertise from the following sectors:
1. Clinics & Hospitals
o Contributing healthcare knowledge to design an optimal user experience for both patients and healthcare operators.
o Providing expertise to develop relevant AI algorithms based on real-world clinical practices and requirements.
2. Pharmaceutical Companies & Medical Research Centers
o Offering insights into the types of data and data analytics needed for research and clinical trials.
o Ensuring the effective use of healthcare data to drive innovation in drug discovery and treatment protocols.
3. Medical Device Providers
o Supplying medical devices equipped with The startup's DVCO technology to enable seamless data capture and sharing.
4. AI Companies
o Leveraging healthcare data to develop innovative AI algorithms for:
Disease prediction and prevention.
Emergency assistance and intervention.
5. Front-End Web Application Development Companies
o Designing and developing user-centric front-end interfaces to ensure an optimal and intuitive user experience for all stakeholders.
6. IT Service Providers
o Integrating the Health Data Exchange Hub within existing clinical system architectures.
o Providing the infrastructure and technical support required to deploy and operate the Health Data Exchange Hub efficiently.
By combining the expertise of partners across healthcare, technology, and research sectors, the project will create a robust ecosystem capable of securely managing health data, fostering AI-driven innovation, and improving patient outcomes. This collaboration ensures that the Health Data Exchange Hub and Digital Twin Framework will meet real-world needs, comply with evolving data regulations, and drive personalized, data-driven healthcare solutions across Europe
Key Benefit for Consortium Partners:
1. For hospitals and device manufacturers, DVCO empowers patients to control data sharing from devices such as wearables and medical sensors, enabling compliance by design with both GDPR and the Data Act. For pharmaceutical companies and research organizations, DVCO provides secure access to real-time health data, accelerating clinical trials and enhancing research while ensuring compliance with GDPR and aligning with the Data Spaces architecture.
2. For hospitals, RELE ensures that only healthcare providers authorized directly by the patient can access specific health records, enhancing GDPR compliance and patient trust. For pharmaceutical companies and research institutions, RELE enables privacy-compliant research by allowing patients to grant selective access to the necessary health data for trials or studies, while ensuring alignment with the Health Data Spaces architecture for secure and compliant cross-border data exchange.
3. Healthcare providers, researchers, and device manufacturers can securely manage and exchange health data in real-time, while patients maintain control over their data. The open-stheirce nature of DOP ensures easy integration of The startup Privacy Enhancing Technologies into existing systems, fostering interoperability and collaboration across the consortium while also enabling participation in European Health Data Spaces for secure, compliant data exchange on a large scale.
Partner Sought
- Expected Role of a Partner
-
The ideal consortium will bring together expertise from the following sectors:
1. Clinics & Hospitals
o Contributing healthcare knowledge to design an optimal user experience for both patients and healthcare operators.
o Providing expertise to develop relevant AI algorithms based on real-world clinical practices and requirements.
2. Pharmaceutical Companies & Medical Research Centers
o Offering insights into the types of data and data analytics needed for research and clinical trials.
o Ensuring the effective use of healthcare data to drive innovation in drug discovery and treatment protocols.
3. Medical Device Providers
o Supplying medical devices equipped with The startup's DVCO technology to enable seamless data capture and sharing.
4. AI Companies
o Leveraging healthcare data to develop innovative AI algorithms for:
Disease prediction and prevention.
Emergency assistance and intervention.
5. Front-End Web Application Development Companies
o Designing and developing user-centric front-end interfaces to ensure an optimal and intuitive user experience for all stakeholders.
6. IT Service Providers
o Integrating the Health Data Exchange Hub within existing clinical system architectures.
o Providing the infrastructure and technical support required to deploy and operate the Health Data Exchange Hub efficiently.
By combining the expertise of partners across healthcare, technology, and research sectors, the project will create a robust ecosystem capable of securely managing health data, fostering AI-driven innovation, and improving patient outcomes. This collaboration ensures that the Health Data Exchange Hub and Digital Twin Framework will meet real-world needs, comply with evolving data regulations, and drive personalized, data-driven healthcare solutions across Europe
Key Benefit for Consortium Partners:
1. For hospitals and device manufacturers, DVCO empowers patients to control data sharing from devices such as wearables and medical sensors, enabling compliance by design with both GDPR and the Data Act. For pharmaceutical companies and research organizations, DVCO provides secure access to real-time health data, accelerating clinical trials and enhancing research while ensuring compliance with GDPR and aligning with the Data Spaces architecture.
2. For hospitals, RELE ensures that only healthcare providers authorized directly by the patient can access specific health records, enhancing GDPR compliance and patient trust. For pharmaceutical companies and research institutions, RELE enables privacy-compliant research by allowing patients to grant selective access to the necessary health data for trials or studies, while ensuring alignment with the Health Data Spaces architecture for secure and compliant cross-border data exchange.
3. Healthcare providers, researchers, and device manufacturers can securely manage and exchange health data in real-time, while patients maintain control over their data. The open-stheirce nature of DOP ensures easy integration of The startup Privacy Enhancing Technologies into existing systems, fostering interoperability and collaboration across the consortium while also enabling participation in European Health Data Spaces for secure, compliant data exchange on a large scale. - Type and Size of Partner
- Big company
- SME 11-49
- SME 50 - 249
- R&D Institution
- Other
- University
- Type of partnership
- Research and development cooperation agreement
Call details
- Framework program
- Horizon Europe
- Call title and identifier
-
IHI Call 9 - Topic 4: Boosting innovation through the exploitation of digitalisation and data exchange in healthcare
- Coordinator required
-
Yes
- Deadline for EoI
- Deadline of the call
- Web link to the call
- https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/IHI_Call9…
- Horizon Europe
Dissemination
- Technology keywords
- 01003008 - Data Processing / Data Interchange, Middleware
- 06005003 - Health information management
- Market keywords
- 05007007 - Other medical/health related (not elsewhere classified)
- 02006005 - Big data management
- Sector Groups Involved
- Health
- Digital
- Targeted countries
- All countries